Erez Naaman is the CTO and co-founder of Scopio Labs, a company specializing in hematology that's revolutionizing diagnostics through artificial intelligence and full-field morphology.
In this episode, we discuss the topic of digital transformation in diagnostics, with a special focus on the impact and the future potential of artificial intelligence. We talk more generally about laboratory medicine and the role of diagnostics there before diving deeper into the obvious impacts of COVID and the accelerated digitalization (not to be confused with digitization, which Erez also points out and explains).
Links & mentions: